May 23, 2025

Regular Exercise Slows Memory Decline in Seniors

In a study of older adults with memory problems, those who exercised regularly for 12 months had less cognitive decline than those who did not receive any intervention.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 22, 2025

Cardiogenic Shock in Women: Treatment Disparities Persist

New expert consensus statement reveals that women with cardiogenic shock face significant treatment disparities and outlines evidence-based recommendations for improving outcomes.

Conexiant

May 21, 2025

Smokers, High f-Hb Need More Colonoscopies

In a multicenter study of over 600 patients, researchers found that higher fecal hemoglobin levels and smoking increased the likelihood of needing a follow-up colonoscopy after capsule endoscopy.

Conexiant

May 20, 2025

No Timing Impact Found in MMAE Outcomes: Study 

A large multicenter study found no significant differences in recurrence or success rates whether middle meningeal artery embolization was done before or after surgery in treating chronic subdural hematoma.

Conexiant

May 19, 2025

CAA Imaging Markers Linked to Plasma Biomarkers

A large cohort study in South Korea found that cerebral amyloid angiopathy imaging markers were linked to increased Alzheimer’s-related plasma biomarkers and cognitive decline, partly mediated by brain amyloid buildup.

Conexiant

May 19, 2025

New Metric Improves Colonoscopy Quality Performance Tracking

Researchers analyzed over 92,000 colonoscopies and proposed a new quality metric—case-mix adjusted polyp count—that outperformed traditional benchmarks in tracking detection performance.

Conexiant

May 16, 2025

Delandistrogene Moxeparvovec: Efficacy Evidence Questioned

The AAN Guidelines Subcommittee review finds delandistrogene moxeparvovec for DMD failed to meet primary functional outcomes despite FDA approval.

Conexiant

May 16, 2025

Removing NET on MRI Extends Glioblastoma Survival

A new multinational study found that removing the full extent of noncontrast-enhanced tumor seen on MRI scans led to significantly longer survival in patients with IDH wild-type glioblastoma.

Conexiant